Clinical trial No longer in our active list Interventional Ages 55 to 75

Effects of N-acetylcysteine on Obstructive Sleep Apnea

Official title: Basis of Sex-specific Therapeutic Responses to Obstructive Sleep Apnea (OSA): a Trial of N-acetylcysteine (NAC) in Obstructive Sleep Apnea (OSA)

Run by NYU Langone Health · NCT06311045 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests if taking N-acetylcysteine can help people with obstructive sleep apnea feel better while they use their breathing machines.

More Obstructive Sleep Apnea trials

Quick facts

Study typeInterventional
Ages55 Years to 75 Years
SexAll
Enrollment206 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
Trial IDNCT06311045 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with obstructive sleep apnea, exhibiting an apnea-hypopnea index of 15 events/hour or more, and not having diabetes.

Probably not a fit

Patients with a body mass index of 40 kg/m2 or higher, or those currently using diabetes medications, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of N-acetylcysteine (NAC) compared to a placebo in individuals with significant obstructive sleep apnea (OSA) who are undergoing positive airway pressure therapy. Over a period of four weeks, the study aims to assess whether NAC can induce sex-specific changes in oxidative stress, inflammation, and endothelial dysfunction in these patients. Participants will be monitored for their apnea-hypopnea index and other health metrics to evaluate the efficacy of the intervention.

Why it matters

Potential benefit: If successful, this study could provide a new therapeutic option for improving health outcomes in patients with obstructive sleep apnea.

How similar studies have gone: While the specific use of NAC in this context may be novel, similar studies exploring antioxidant therapies for sleep apnea have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Apnea-hypopnea index ≥15 events/hr on portable sleep monitoring
* HbA1c \<6.5%

Exclusion Criteria:

* Body mass index (BMI) ≥40 kg/m2;
* Diagnosis of diabetes mellitus, defined as the use of any diabetes medication (including glucagon like peptide \[GLP\]-1 agonists) currently or in the previous three months or HbA1c ≥6.5%;
* Shift work (i.e., working hours that routinely cause sleep initiation after 1:00 a.m.);
* Another major sleep disorder (i.e., circadian rhythm disorder, any history of narcolepsy, concurrently diagnosed or medication-treated restless legs syndrome, concurrently diagnosed or medication-treated chronic insomnia with the exception of antidepressant therapy);
* Regular use (more than twice/week) of an opioid/narcotic, benzodiazepine, or prescription sleep medication other than antidepressants currently or within the last month;
* The use of N-acetylcysteine in any form (oral, intravenous, inhaled) in the last seven days
* The use of other over-the-counter antioxidant therapies including vitamin C or vitamin E in the preceding 10 days
* History of reduced ejection fraction heart failure, or chronic cardiac arrhythmia requiring medication or treatment;
* Unstable or uncontrolled medical or psychiatric comorbidity requiring hospitalization or change in medication during the previous three months;
* Use of biologics or immune modulators in the last year;
* Use of systemic steroids during the previous three months;
* Current tobacco smoking;
* Inability to sign informed consent;
* Currently use of positive airway pressure therapy or another OSA treatment (e.g., hypoglossal nerve stimulator, oral device);
* Recent history of alcoholism or drug abuse (within the last three months)
* Neurological condition that requires ongoing pharmacological therapy (e.g., Parkinson's disease, Alzheimer's dementia, multiple sclerosis, other degenerative neurological disease).
* Pregnancy

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.